Methadone, technology and outcomes

October 5, 2013February 28, 2022 ~ Jason Schwartz ~ 3 Comments

Substance Matters has a post about the use of new technologies in methadone maintenance. Patients who use a web-based intervention (TES) instead of half of their traditional counseling did better than those with traditional counseling as part of their methadone treatment. It provokes important questions about the usefulness of new technologies and how they might … Continue reading Methadone, technology and outcomes

Venture capital and methadone

April 2, 2013February 28, 2022 ~ Jason Schwartz ~ 1 Comment

There must be a lot of money available if private equity firms are willing to expose themselves to this much risk: At least five state legislatures are considering bills to tighten oversight of methadone clinics after allegations that take-home doses of the drug are contributing to illegal street sales, misuse and deaths. Measures in West … Continue reading Venture capital and methadone

$2.2 billion invested in addiction treatment and behavioral health companies

February 11, 2013February 28, 2022 ~ Jason Schwartz ~ 3 Comments

Businessweek has a damning investigation of for-profit methadone treatment. And, who knew that Bain Capital is such a player? Since Jan. 1, 2009, CRC’s clinics haven’t met staffing standards more than 50 times, regulatory records from 15 states show. Clinics were cited 80 times for failing to document that they gave patients enough counseling. … Continue reading $2.2 billion invested in addiction treatment and behavioral health companies